Nagashima, T.; Ochiai, K.; Takizawa, Y.; Koike, Y.; Saito, T.; Muramatsu, A.; Azakami, D.; Machida, Y.; Bonkobara, M.; Ishiwata, T.;
et al. Antitumor Effect of mTOR1/2 Dual Inhibitor AZD8055 in Canine Pulmonary Carcinoma. Cancers 2025, 17, 1991.
https://doi.org/10.3390/cancers17121991
AMA Style
Nagashima T, Ochiai K, Takizawa Y, Koike Y, Saito T, Muramatsu A, Azakami D, Machida Y, Bonkobara M, Ishiwata T,
et al. Antitumor Effect of mTOR1/2 Dual Inhibitor AZD8055 in Canine Pulmonary Carcinoma. Cancers. 2025; 17(12):1991.
https://doi.org/10.3390/cancers17121991
Chicago/Turabian Style
Nagashima, Tomokazu, Kazuhiko Ochiai, Yuka Takizawa, Youta Koike, Takahiro Saito, Asumi Muramatsu, Daigo Azakami, Yukino Machida, Makoto Bonkobara, Toshiyuki Ishiwata,
and et al. 2025. "Antitumor Effect of mTOR1/2 Dual Inhibitor AZD8055 in Canine Pulmonary Carcinoma" Cancers 17, no. 12: 1991.
https://doi.org/10.3390/cancers17121991
APA Style
Nagashima, T., Ochiai, K., Takizawa, Y., Koike, Y., Saito, T., Muramatsu, A., Azakami, D., Machida, Y., Bonkobara, M., Ishiwata, T., & Michishita, M.
(2025). Antitumor Effect of mTOR1/2 Dual Inhibitor AZD8055 in Canine Pulmonary Carcinoma. Cancers, 17(12), 1991.
https://doi.org/10.3390/cancers17121991
